-

AIS Healthcare Announces New Chief Legal & Compliance Officer

DALLAS--(BUSINESS WIRE)--AIS Healthcare, the leading provider of targeted drug delivery and infusion care solutions, is announcing the appointment of Sybil Rajan as Chief Legal Officer and Chief Compliance Officer. In this role, Sybil will lead AIS Healthcare’s Legal and Compliance departments, building upon an already strong foundation to support safe, strategic growth in an increasingly complex regulatory environment.

“We are so thrilled to welcome Sybil,” said Simon Castellanos, AIS Healthcare’s Chief Executive Officer. “Her proven track record of success and process improvement, combined with her commitment to quality of care will be key as we continue to strengthen our legal and compliance team.”

Sybil brings extensive leadership experience in both healthcare and administrative roles. Most recently, she served as General Counsel and Chief Administrative Officer at GenesisCare, an oncology care company, where she led the Legal, People, and Culture departments through a post-bankruptcy turnaround and successful sale. Following this success, she continued to support the organization as an Advisor to the Board of Directors.

“I’m very excited to join AIS and contribute to our shared mission,” said Sybil. “Together we will navigate an ever-changing legal landscape to deliver high-quality, patient-centered care.”

Sybil holds a Juris Doctor from Cornell Law School, a Master of Public Health from The University of Texas Health Science Center at Houston, and a Bachelor of Business Administration in Business Honors and Finance from The University of Texas at Austin.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com.

Contacts

Simon Castellanos
877.443.4006

AIS Healthcare


Release Versions

Contacts

Simon Castellanos
877.443.4006

More News From AIS Healthcare

Atlanta, GA Is the Newest AIC Infusion Center Location, Expanding Its National Presence

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is proud to announce the latest opening of an Advanced Infusion Care Center (AICC). This new location in Atlanta, GA is the latest example of AIC’s ongoing growth and commitment to helping people access compassionate, high-quality infusion services across the country. Establishing additional infusion center sites reinforces AIC’s strategic dedication to ad...

New Outpatient Infusion Center Opening in Marietta, GA Expands the National Presence of Advanced Infusion Care

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce the opening of another Advanced Infusion Care Center (AICC). This latest one is in Marietta, GA represents a significant step forward in AIC’s ongoing expansion and its commitment to increasing access to compassionate, high-quality infusion services across the country. The opening of more and more AICC sites highlights AIC’s strategi...

Advanced Infusion Care (AIC) Now Offers Kedrion Biopharma’s YIMMUGO® (Immune Globulin Intravenous Human-Dira, 10% Liquid)

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older. Approved by the U.S. Food and Drug Administration in June 2024, YIMMUGO® is now available at all AIC locations. The nationally accredited infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or in an infusion center set...
Back to Newsroom